Immune adjuvant efficacy of CpG oligonucleotide in cancer treatment is founded specifically upon TLR9 function in plasmacytoid dendritic cells

Stefan Nierkens, Martijn H den Brok, Zacharias Garcia, Susan Togher, Jori Wagenaars, Melissa Wassink, Louis Boon, Theo J Ruers, Carl G Figdor, Stephen P Schoenberger, Gosse J Adema, Edith M Janssen

Research output: Contribution to journal › Article › Academic › peer-review

Fingerprint

Dive into the research topics of 'Immune adjuvant efficacy of CpG oligonucleotide in cancer treatment is founded specifically upon TLR9 function in plasmacytoid dendritic cells'. Together they form a unique fingerprint.

Immunology and Microbiology